HALO logo
halo search icon
XTL Biopharmaceuticals Ltd. Sponsored ADR
XTL Biopharmaceuticals Ltd. Sponsored ADR
XTLB · NAS

XTL Biopharmaceuticals Ltd. Sponsored ADR

US$2.57

Price Arrow0.04 (1.58%)
20/05/2026 04:00:00 PM
Hammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

XTL Biopharmaceuticals Ltd. Sponsored ADR Overview

XTLB Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About XTLB

icon

Telephone

972.3.611.6600

icon

Address

26 Ben-Gurion Street, Ramat Gan, Tel Aviv 5112001

Description

XTL Biopharmaceuticals Ltd. engages in the acquisition and development of pharmaceutical drugs for the treatment of autoimmune diseases. Its product pipeline includes hCDR1 and rHuEPO. The company was founded on March 9, 1993 and is headquartered in Ramat Gan, Israel.

XTLB Price Chart

Key Stats

Market Cap

US$6.14M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.12 - 10.28

Trade Value (12mth)

US$565,650.00

1 week

-3.07%

1 month

2.43%

YTD

5.5%

1 year

-39.76%

All time high

2400.00

Key Fundamentals

EPS 3 yr Growth

-287.40%

EBITDA Margin

-437.50%

Operating Cashflow

-$2m

Free Cash Flow Return

-41.60%

ROIC

-27.00%

Interest Coverage

-22.90

Quick Ratio

0.60

Other Data

Shares Outstanding (Fully Diluted)

2m

HALO Sector

Healthcare

Next Company Report Date

N/A

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

XTLB Announcements

Latest Announcements

DateAnnouncements
16 May 26
07 May 26
29 April 26
21 March 26
11 March 26

XTLB Fundamentals

Per Share Records

Historical data

Forecast data

USD2020202120222023202220232024202520262027
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-0.98-1.3-0.61locklocklock
EPS (Fully Diluted)
$locklocklocklock-0.98-1.3-0.61locklocklock
Growth
%locklocklocklock-399.8-32.652.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS)?
Halo FAQ
The current share price of XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) is USD$2.57.
What is the 52-week high share price for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS)?
Halo FAQ
The 52-week high share price for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) is USD$10.28.
What is the 52-week low share price for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS)?
Halo FAQ
The 52-week low share price for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) is USD$2.12.
What is the dividend yield for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS)?
Halo FAQ
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) does not pay a dividend.
What was XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) last dividend payment?
Halo FAQ
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) does not pay a dividend.
What is the franking level for XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS)?
Halo FAQ
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) has a franking level of 0.00%.
In which sector is XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) classified?
Halo FAQ
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.